AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33094868 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based treatment (FBT)
Number of subjects: 158
Study 33094868 — intervention group
Group type: COMPARATOR
Intervention: Systemic family treatment
Number of subjects: 158
Study 616120200 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept 2.0mg
Number of subjects: 906
Study 616120200 — intervention group
Group type: COMPARATOR
Intervention: Ranibizumab 0.5mg
Number of subjects: 906
Study 616120200 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept
Number of subjects: 906
Study 616120200 — intervention group
Group type: COMPARATOR
Intervention: Ranibizumab
Number of subjects: 906
Study 616120200 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimonthly aflibercept
Number of subjects: 906
Study 34780095 — intervention group
Group type: EXPERIMENTAL
Intervention: NAL‐ER162 (162 mg twice daily)
Number of subjects: 63
Study 34780095 — intervention group
Group type: EXPERIMENTAL
Intervention: NAL‐ER81 (81 mg twice daily)
Number of subjects: 63
Study 34780095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 33596019 — intervention group
Group type: EXPERIMENTAL
Intervention: Tono-Pen AVIA (TPA)
Number of subjects: 23
Study 33596019 — intervention group
Group type: COMPARATOR
Intervention: Handheld Goldmann applanation tonometer (GAT)
Number of subjects: 23
Study 33596019 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of TPA and GAT
Number of subjects: 23
Study 33596019 — intervention group
Group type: EXPERIMENTAL
Intervention: Age increase
Number of subjects: 23
Study 33596019 — intervention group
Group type: EXPERIMENTAL
Intervention: GAT IOP increase
Number of subjects: 23
Study 33596019 — intervention group
Group type: EXPERIMENTAL
Intervention: CCT increase
Number of subjects: 23
Study 32933995 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton Pump Inhibitor (PPI) use
Number of subjects: 1360
Study 32933995 — intervention group
Group type: COMPARATOR
Intervention: Atezolizumab
Number of subjects: 1360
Study 32933995 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 1360
Study 35412366 — intervention group
Group type: EXPERIMENTAL
Intervention: Major debulking or total/near-total resection
Number of subjects: 50
Study 35412366 — intervention group
Group type: EXPERIMENTAL
Intervention: Leptomeningeal metastatic dissemination before treatment
Number of subjects: 50
Study 34086752 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support stress management
Number of subjects: 53
Study 34086752 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 53
Study 35709430 — intervention group
Group type: EXPERIMENTAL
Intervention: Food voucher plus pantry
Number of subjects: 117
Study 35709430 — intervention group
Group type: EXPERIMENTAL
Intervention: Home grocery delivery plus pantry
Number of subjects: 117
Study 35709430 — intervention group
Group type: COMPARATOR
Intervention: Hospital cancer clinic-based food pantry
Number of subjects: 117
Study 32891738 — intervention group
Group type: EXPERIMENTAL
Intervention: D-index-guided early antifungal therapy (DET) using micafungin
Number of subjects: 180
Study 32891738 — intervention group
Group type: COMPARATOR
Intervention: Empirical antifungal therapy (EAT) using micafungin
Number of subjects: 180
Study 35857327 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message intervention stating a vaccine had been reserved, with scheduled vaccination date and follow-up reminders.
Number of subjects: 2000
Study 35857327 — intervention group
Group type: COMPARATOR
Intervention: Control group (no text message intervention).
Number of subjects: 2000
Study 35857327 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message intervention.
Number of subjects: 2000
Study 35857327 — intervention group
Group type: COMPARATOR
Intervention: Control group.
Number of subjects: 2000
Study 33492269 — intervention group
Group type: EXPERIMENTAL
Intervention: Anisodamine hydrobromide (group A)
Number of subjects: 107
Study 33492269 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (group N)
Number of subjects: 107
Study 33492269 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (group C)
Number of subjects: 107
Study 36047480 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational interventions supported by new technology decision tools for T2DM patients
Number of subjects: 2334
Study 36047480 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 2334
Study 34563211 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra (Kineret®), a human recombinant interleukin‐1 receptor antagonist (rhIL1ra)
Number of subjects: 20
Study 34563211 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 20
Study 34617520 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucoadhesive paste containing PFLC (0.05%) and AFMC (0.01%)
Number of subjects: 30
Study 34617520 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 34617520 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucoadhesive paste containing PFLC and AFMC
Number of subjects: 30
Study 32917571 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous fat grafting
Number of subjects: 10
Study 32178858 — intervention group
Group type: EXPERIMENTAL
Intervention: Remimazolam (HR-7056)
Number of subjects: 87
Study 32178858 — intervention group
Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 87
Study 32178858 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 87
Study 32178858 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant rate infusion of Remimazolam
Number of subjects: 87
Study 34294072 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc chloride mouthwash (7.5 ml, rinsed every 8 hours for 2 minutes)
Number of subjects: 96
Study 34294072 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc chloride mouthwash
Number of subjects: 96
Study 34294072 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthwash
Number of subjects: 96
Study 32129114 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐Harm Antipathy Scale–Swedish Revised (SHAS‐SR)
Number of subjects: 596
Study 36295581 — intervention group
Group type: EXPERIMENTAL
Intervention: HBOT + OS
Number of subjects: 171
Study 36295581 — intervention group
Group type: EXPERIMENTAL
Intervention: HBOT
Number of subjects: 171
Study 32951067 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5 g Litesse®Ultra (PDX)
Number of subjects: 18
Study 32951067 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 18
Study 32868594 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation training
Number of subjects: 31
Study 32868594 — intervention group
Group type: COMPARATOR
Intervention: Video instruction
Number of subjects: 31
Study 36215323 — intervention group
Group type: COMPARATOR
Intervention: Monthly sulfadoxine/pyrimethamine‐amodiaquine (SP‐AQ)
Number of subjects: 246
Study 36215323 — intervention group
Group type: COMPARATOR
Intervention: Monthly dihydroartemisinin‐piperaquine (DP)
Number of subjects: 246
Study 34121333 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-sodium oxybate (LXB) 4.5 g
Number of subjects: 0
Study 34121333 — intervention group
Group type: COMPARATOR
Intervention: Sodium oxybate (SXB) 4.5 g
Number of subjects: 0
Study 34121333 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-sodium oxybate (LXB) and sodium oxybate (SXB)
Number of subjects: 0
Study 34121333 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-sodium oxybate (LXB)
Number of subjects: 0
Study 33577574 — intervention group
Group type: EXPERIMENTAL
Intervention: Microwave ablation (MWA)
Number of subjects: 17
Study 33577574 — intervention group
Group type: COMPARATOR
Intervention: Conventional transarterial chemoembolization (C‐TACE)
Number of subjects: 17
Study 32058361 — intervention group
Group type: COMPARATOR
Intervention: Load carriage at sea level (SL)
Number of subjects: 9
Study 32058361 — intervention group
Group type: EXPERIMENTAL
Intervention: Load carriage at high altitude (HA; 3000 m)
Number of subjects: 9
Study 32058361 — intervention group
Group type: EXPERIMENTAL
Intervention: Load carriage at moderate altitude (MA; 2000 m)
Number of subjects: 9
Study 32058361 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate during TT
Number of subjects: 9
Study 35550405 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoidance arm (functional lung avoidance based on 3He MRI)
Number of subjects: 27
Study 35550405 — intervention group
Group type: COMPARATOR
Intervention: Standard arm (standard radiation therapy plan without 3He MRI)
Number of subjects: 27
Study 35550405 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 27
Study 33601689 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple chronotherapy
Number of subjects: 44
Study 33601689 — intervention group
Group type: COMPARATOR
Intervention: Alternative protocol
Number of subjects: 44
Study 32212805 — intervention group
Group type: EXPERIMENTAL
Intervention: Gum-chewing group (n=40)
Number of subjects: 82
Study 32212805 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=42)
Number of subjects: 82
Study 34896033 — intervention group
Group type: EXPERIMENTAL
Intervention: 22-gauge needle
Number of subjects: 40
Study 34896033 — intervention group
Group type: EXPERIMENTAL
Intervention: 19-gauge needle
Number of subjects: 40
Study 34896033 — intervention group
Group type: EXPERIMENTAL
Intervention: 22-gauge and 19-gauge needles
Number of subjects: 40
Study 33241924 — intervention group
Group type: EXPERIMENTAL
Intervention: Home gardening intervention (agricultural training and inputs, nutrition and public health counselling)
Number of subjects: 1006
Study 33241924 — intervention group
Group type: EXPERIMENTAL
Intervention: Home gardening intervention
Number of subjects: 1006
Study 33241924 — intervention group
Group type: COMPARATOR
Intervention: Standard services provided by agriculture and health workers (Control)
Number of subjects: 1006
Study 35302931 — intervention group
Group type: EXPERIMENTAL
Intervention: Session Model (SM)
Number of subjects: 40
Study 35302931 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily Model (DM)
Number of subjects: 40
Study 35302931 — intervention group
Group type: COMPARATOR
Intervention: Weekly Model (WM)
Number of subjects: 40
Study 35302931 — intervention group
Group type: EXPERIMENTAL
Intervention: All Groups
Number of subjects: 40
Study 35495896 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing intervention based on intelligent grip strength system
Number of subjects: 100
Study 33277303 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic risk of type 2 diabetes
Number of subjects: 463469
Study 32398047 — intervention group
Group type: EXPERIMENTAL
Intervention: Canrenone (200 mg intravenously within 2-3 min)
Number of subjects: 80
Study 32398047 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline within the same time)
Number of subjects: 80
Study 34470583 — intervention group
Group type: EXPERIMENTAL
Intervention: MMPI‐3 over‐reporting scales
Number of subjects: 310
Study 34470583 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 310
Study 32446881 — intervention group
Group type: EXPERIMENTAL
Intervention: Edetate disodium
Number of subjects: 633
Study 33175348 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Together (ET)
Number of subjects: 9
Study 33175348 — intervention group
Group type: COMPARATOR
Intervention: Exercise Separately (ES)
Number of subjects: 9
Study 33175348 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (ET and ES)
Number of subjects: 9
Study 34016347 — intervention group
Group type: EXPERIMENTAL
Intervention: VSTAP (3 days of 90 min exercise: 10 min at 30% of PPO + 80 min at 50% of PPO) in heat (35°C-50% RH)
Number of subjects: 12
Study 34016347 — intervention group
Group type: EXPERIMENTAL
Intervention: VSTAP (3 days of 90 min exercise)
Number of subjects: 12
Study 32978425 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D deficiency
Number of subjects: 793
Study 32978425 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D insufficiency
Number of subjects: 793
Study 32978425 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean vitamin D level
Number of subjects: 793
Study 32978425 — intervention group
Group type: EXPERIMENTAL
Intervention: Excess weight during the 1st trimester (BMI≥25 kg/m2)
Number of subjects: 793
Study 32978425 — intervention group
Group type: EXPERIMENTAL
Intervention: Arab ethnic group/dark skin colour
Number of subjects: 793
Study 32978425 — intervention group
Group type: EXPERIMENTAL
Intervention: Winter/spring season
Number of subjects: 793
Study 32978425 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of milk
Number of subjects: 793
Study 32978425 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of yogurt
Number of subjects: 793
Study 32978425 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 793
Study 32978425 — intervention group
Group type: EXPERIMENTAL
Intervention: Social class
Number of subjects: 793
Study 35791724 — intervention group
Group type: EXPERIMENTAL
Intervention: Mnemonic Strategy Training (MST)
Number of subjects: 0
Study 35791724 — intervention group
Group type: COMPARATOR
Intervention: Spaced Retrieval Training (SRT)
Number of subjects: 0
Study 34518248 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture therapy
Number of subjects: 170
Study 34518248 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 170
Study 33971408 — intervention group
Group type: EXPERIMENTAL
Intervention: Freshly formed ferric hydroxide (FFFH) under acidic conditions (pH = 4)
Number of subjects: 47
Study 33971408 — intervention group
Group type: EXPERIMENTAL
Intervention: Freshly formed ferric hydroxide (FFFH) under neutral conditions (pH = 7)
Number of subjects: 47
Study 33971408 — intervention group
Group type: EXPERIMENTAL
Intervention: Freshly formed ferric hydroxide (FFFH) under alkaline conditions (pH = 10)
Number of subjects: 47
Study 33971408 — intervention group
Group type: EXPERIMENTAL
Intervention: QSAR models established using multiple linear regression (MLR) analysis
Number of subjects: 47
Study 32595160 — intervention group
Group type: EXPERIMENTAL
Intervention: New warnings on plain packs with innovative texts and pictures based on motivational leverage and harm reduction.
Number of subjects: 0
Study 32595160 — intervention group
Group type: COMPARATOR
Intervention: Plain pack without warning
Number of subjects: 0
Study 32595160 — intervention group
Group type: COMPARATOR
Intervention: Plain pack with conventional warning
Number of subjects: 0
Study 32595160 — intervention group
Group type: COMPARATOR
Intervention: Branded pack with conventional warning
Number of subjects: 0
Study 32595160 — intervention group
Group type: EXPERIMENTAL
Intervention: Monetarily incentivised measures
Number of subjects: 0
Study 33175237 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental Group I (EG I) - Theoretically Consistent Approach (TCA), Mindfulness-Based Eating Training (MET), Cash’s Prevention of Body Image Disturbances (CPBID)
Number of subjects: 129
Study 33175237 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental Group II (EG II) - Eclectic Approach (EA), Mindfulness-Based Eating Training (MET), Cash’s Prevention of Body Image Disturbances (CPBID)
Number of subjects: 129
Study 33175237 — intervention group
Group type: COMPARATOR
Intervention: Wait List Control Group (CG)
Number of subjects: 129
Study 33256850 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct admission
Number of subjects: 1696
Study 33256850 — intervention group
Group type: COMPARATOR
Intervention: Admission through EDs
Number of subjects: 1696
Study 35483886 — intervention group
Group type: EXPERIMENTAL
Intervention: FODMAP-lowering diet application
Number of subjects: 459
Study 35483886 — intervention group
Group type: COMPARATOR
Intervention: OB (40 mg three times a day)
Number of subjects: 459
Study 34302924 — intervention group
Group type: EXPERIMENTAL
Intervention: RFM visible during PPV
Number of subjects: 288
Study 34302924 — intervention group
Group type: COMPARATOR
Intervention: RFM non-visible during PPV
Number of subjects: 288
Study 34302924 — intervention group
Group type: EXPERIMENTAL
Intervention: RFM visible
Number of subjects: 288
Study 34302924 — intervention group
Group type: COMPARATOR
Intervention: RFM non-visible
Number of subjects: 288
Study 34973304 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine, 30 mL to 14 mL
Number of subjects: 45
Study 34973304 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine, 14 mL
Number of subjects: 45
Study 34973304 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine, 30 mL
Number of subjects: 45
Study 34973304 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine, 12 mL
Number of subjects: 45
Study 34684307 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Youngsters, Healthy Dads intervention
Number of subjects: 0
Study 34684307 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study 35427803 — intervention group
Group type: EXPERIMENTAL
Intervention: PDS 10 mg/ml
Number of subjects: 220
Study 35427803 — intervention group
Group type: EXPERIMENTAL
Intervention: PDS 40 mg/ml
Number of subjects: 220
Study 35427803 — intervention group
Group type: EXPERIMENTAL
Intervention: PDS 100 mg/ml
Number of subjects: 220
Study 35427803 — intervention group
Group type: COMPARATOR
Intervention: Monthly ranibizumab 0.5 mg
Number of subjects: 220
Study 34280067 — intervention group
Group type: EXPERIMENTAL
Intervention: Meloxicam IV 30 mg
Number of subjects: 181
Study 34280067 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 181
Study 33176315 — intervention group
Group type: EXPERIMENTAL
Intervention: F + PGA (225 ppm F‐ + 0.1% PGA)
Number of subjects: 12
Study 33176315 — intervention group
Group type: EXPERIMENTAL
Intervention: F (225 ppm F‐)
Number of subjects: 12
Study 33176315 — intervention group
Group type: EXPERIMENTAL
Intervention: F + Sn (225 ppm F‐ + SnCl2, 800 ppm Sn2+)
Number of subjects: 12
Study 33176315 — intervention group
Group type: COMPARATOR
Intervention: Negative control (distilled water)
Number of subjects: 12
Study 34337869 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone intervention based on motivational health coaching
Number of subjects: 106
Study 34337869 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 106
Study 35393383 — intervention group
Group type: EXPERIMENTAL
Intervention: Metal plates
Number of subjects: 30
Study 35393383 — intervention group
Group type: COMPARATOR
Intervention: Resorbable plates
Number of subjects: 30
Study 33524326 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-D Plates
Number of subjects: 44
Study 33524326 — intervention group
Group type: COMPARATOR
Intervention: Miniplates
Number of subjects: 44
Study 32275030 — intervention group
Group type: COMPARATOR
Intervention: PECS1 block (Group P)
Number of subjects: 30
Study 32275030 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined PECS1 and TTM blocks (Group PT)
Number of subjects: 30
Study 35689289 — intervention group
Group type: EXPERIMENTAL
Intervention: Axial ablation (AA) of varicose veins
Number of subjects: 0
Study 35689289 — intervention group
Group type: COMPARATOR
Intervention: Terminal interruption of the reflux source (TIRS) by peri-ulcer foam sclerotherapy
Number of subjects: 0
Study 34086740 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone application for CTCAE conform symptom reporting and tracking
Number of subjects: 66
Study 34086740 — intervention group
Group type: COMPARATOR
Intervention: Standard care (no smartphone reporting)
Number of subjects: 66
Study 36321459 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan (97/103 mg twice daily)
Number of subjects: 5661
Study 36321459 — intervention group
Group type: COMPARATOR
Intervention: Ramipril (5 mg twice daily)
Number of subjects: 5661
Study 32049156 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 130
Study 32049156 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 130
Study 34255553 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined hospital-based supervised and home-based unsupervised physical activity sessions (PAS)
Number of subjects: 59
Study 34053745 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined genetically-influenced lower TG and LDL-C
Number of subjects: 11837
Study 34053745 — intervention group
Group type: COMPARATOR
Intervention: Genetically-influenced lower TG only
Number of subjects: 11837
Study 34053745 — intervention group
Group type: COMPARATOR
Intervention: Genetically-influenced lower LDL-C only
Number of subjects: 11837
Study 34053745 — intervention group
Group type: COMPARATOR
Intervention: Reference group (genetically-influenced high TG and LDL-C)
Number of subjects: 11837
Study 34184583 — intervention group
Group type: EXPERIMENTAL
Intervention: Syllable Repetition/Prolonged Sounds subtest of the SNAP Test‐R
Number of subjects: 0
Study 34184583 — intervention group
Group type: EXPERIMENTAL
Intervention: Picture‐Cued subtest of the SNAP Test‐R
Number of subjects: 0
Study 34184583 — intervention group
Group type: EXPERIMENTAL
Intervention: Paragraph subtest of the SNAP Test‐R
Number of subjects: 0
Study 34184583 — intervention group
Group type: EXPERIMENTAL
Intervention: Syllable Repetition subtest of the SNAP Test‐R
Number of subjects: 0
Study 34184583 — intervention group
Group type: EXPERIMENTAL
Intervention: Sound‐Prolonged subtest of the SNAP Test‐R
Number of subjects: 0
Study 34184583 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal syllables and high vowels
Number of subjects: 0
Study 34184583 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall across all SNAP Test‐R subtests
Number of subjects: 0
Study 34526064 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine infusions (six total)
Number of subjects: 66
Study 34526064 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine infusions (six total) in pain group
Number of subjects: 66
Study 34526064 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine infusions (six total) in non-pain group
Number of subjects: 66
Study 32503515 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone (CTRX) plus macrolide
Number of subjects: 263
Study 32503515 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin/sulbactam (ABPC/SBT) plus macrolide
Number of subjects: 263
Study 32440750 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% HP + TiO2
Number of subjects: 36
Study 32440750 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% HP + TiO2 + chitosan
Number of subjects: 36